Vivos Therapeutics Stock Forward View - Triple Exponential Smoothing
| VVOS Stock | USD 1.62 0.09 5.26% |
Vivos Stock outlook is based on your current time horizon.
At this time, the relative strength index (RSI) of Vivos Therapeutics' share price is approaching 37. This entails that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Vivos Therapeutics, making its price go up or down. Momentum 37
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.42) | EPS Estimate Current Year (2.03) | EPS Estimate Next Year (1.25) | Wall Street Target Price 5 | EPS Estimate Current Quarter (0.51) |
Using Vivos Therapeutics hype-based prediction, you can estimate the value of Vivos Therapeutics from the perspective of Vivos Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Vivos Relative Strength Index
The Triple Exponential Smoothing forecasted value of Vivos Therapeutics on the next trading day is expected to be 1.59 with a mean absolute deviation of 0.08 and the sum of the absolute errors of 4.80.Vivos Therapeutics Hype to Price Pattern
Investor biases related to Vivos Therapeutics' public news can be used to forecast risks associated with an investment in Vivos. The trend in average sentiment can be used to explain how an investor holding Vivos can time the market purely based on public headlines and social activities around Vivos Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Vivos Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Vivos Therapeutics.
The Triple Exponential Smoothing forecasted value of Vivos Therapeutics on the next trading day is expected to be 1.59 with a mean absolute deviation of 0.08 and the sum of the absolute errors of 4.80. Vivos Therapeutics after-hype prediction price | USD 1.57 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Vivos Therapeutics to cross-verify your projections. Vivos Therapeutics Additional Predictive Modules
Most predictive techniques to examine Vivos price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Vivos using various technical indicators. When you analyze Vivos charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Vivos Therapeutics Triple Exponential Smoothing Price Forecast For the 31st of January
Given 90 days horizon, the Triple Exponential Smoothing forecasted value of Vivos Therapeutics on the next trading day is expected to be 1.59 with a mean absolute deviation of 0.08, mean absolute percentage error of 0.01, and the sum of the absolute errors of 4.80.Please note that although there have been many attempts to predict Vivos Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Vivos Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Vivos Therapeutics Stock Forecast Pattern
| Backtest Vivos Therapeutics | Vivos Therapeutics Price Prediction | Buy or Sell Advice |
Vivos Therapeutics Forecasted Value
In the context of forecasting Vivos Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Vivos Therapeutics' downside and upside margins for the forecasting period are 0.02 and 6.61, respectively. We have considered Vivos Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Triple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Vivos Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Vivos Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | Huge |
| Bias | Arithmetic mean of the errors | -0.0146 |
| MAD | Mean absolute deviation | 0.0813 |
| MAPE | Mean absolute percentage error | 0.0372 |
| SAE | Sum of the absolute errors | 4.7964 |
Predictive Modules for Vivos Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Vivos Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Vivos Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Vivos Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Vivos Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Vivos Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Vivos Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Vivos Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Vivos Therapeutics' historical news coverage. Vivos Therapeutics' after-hype downside and upside margins for the prediction period are 0.08 and 6.60, respectively. We have considered Vivos Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Vivos Therapeutics is very risky at this time. Analysis and calculation of next after-hype price of Vivos Therapeutics is based on 3 months time horizon.
Vivos Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Vivos Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Vivos Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Vivos Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.58 | 5.03 | 0.05 | 0.07 | 7 Events / Month | 6 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.62 | 1.57 | 3.09 |
|
Vivos Therapeutics Hype Timeline
Vivos Therapeutics is at this time traded for 1.62. The entity has historical hype elasticity of -0.05, and average elasticity to hype of competition of -0.07. Vivos is estimated to decline in value after the next headline, with the price expected to drop to 1.57. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -3.09%, whereas the daily expected return is at this time at -0.58%. The volatility of related hype on Vivos Therapeutics is about 4299.15%, with the expected price after the next announcement by competition of 1.55. About 23.0% of the company outstanding shares are owned by insiders. The company recorded a loss per share of 1.77. Vivos Therapeutics had not issued any dividends in recent years. The entity had 1:25 split on the 27th of October 2023. Given the investment horizon of 90 days the next estimated press release will be in about 7 days. Check out Historical Fundamental Analysis of Vivos Therapeutics to cross-verify your projections.Vivos Therapeutics Related Hype Analysis
Having access to credible news sources related to Vivos Therapeutics' direct competition is more important than ever and may enhance your ability to predict Vivos Therapeutics' future price movements. Getting to know how Vivos Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Vivos Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ALUR | Allurion Technologies | (0.05) | 9 per month | 0.00 | (0.03) | 16.54 | (10.32) | 40.95 | |
| NVNO | enVVeno Medical Corp | (0.70) | 6 per month | 0.00 | (0.16) | 8.13 | (10.09) | 41.30 | |
| CODX | Co Diagnostics | (0.26) | 10 per month | 13.59 | 0.03 | 13.38 | (20.90) | 319.85 | |
| AEMD | Aethlon Medical | 0.10 | 8 per month | 0.00 | (0.13) | 10.51 | (10.29) | 38.52 | |
| COCH | Envoy Medical | (0.01) | 10 per month | 0.00 | (0.07) | 6.94 | (6.17) | 26.25 | |
| ADGM | Adagio Medical Holdings | (0.34) | 10 per month | 0.00 | (0.02) | 11.36 | (8.26) | 64.48 | |
| OSRH | OSR Holdings | (0.16) | 8 per month | 6.21 | 0.05 | 16.07 | (10.14) | 43.23 | |
| ANL | Adlai Nortye Ltd | 0.22 | 6 per month | 5.83 | 0.17 | 15.22 | (11.76) | 42.22 | |
| LPCN | Lipocine | 0.00 | 10 per month | 3.11 | 0.28 | 15.95 | (5.03) | 33.09 | |
| AMS | American Shared Hospital | 0.03 | 8 per month | 0.00 | (0.07) | 2.87 | (2.76) | 10.96 |
Other Forecasting Options for Vivos Therapeutics
For every potential investor in Vivos, whether a beginner or expert, Vivos Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Vivos Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Vivos. Basic forecasting techniques help filter out the noise by identifying Vivos Therapeutics' price trends.Vivos Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Vivos Therapeutics stock to make a market-neutral strategy. Peer analysis of Vivos Therapeutics could also be used in its relative valuation, which is a method of valuing Vivos Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Vivos Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Vivos Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Vivos Therapeutics shares will generate the highest return on investment. By undertsting and applying Vivos Therapeutics stock market strength indicators, traders can identify Vivos Therapeutics entry and exit signals to maximize returns.
| Rate Of Daily Change | 0.95 | |||
| Day Median Price | 1.62 | |||
| Day Typical Price | 1.62 | |||
| Price Action Indicator | (0.04) | |||
| Period Momentum Indicator | (0.09) | |||
| Relative Strength Index | 37.06 |
Vivos Therapeutics Risk Indicators
The analysis of Vivos Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Vivos Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting vivos stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.51 | |||
| Standard Deviation | 4.99 | |||
| Variance | 24.87 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Vivos Therapeutics
The number of cover stories for Vivos Therapeutics depends on current market conditions and Vivos Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Vivos Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Vivos Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Vivos Therapeutics Short Properties
Vivos Therapeutics' future price predictability will typically decrease when Vivos Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Vivos Therapeutics often depends not only on the future outlook of the potential Vivos Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vivos Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 5 M | |
| Cash And Short Term Investments | 6.3 M |
Additional Tools for Vivos Stock Analysis
When running Vivos Therapeutics' price analysis, check to measure Vivos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vivos Therapeutics is operating at the current time. Most of Vivos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vivos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vivos Therapeutics' price. Additionally, you may evaluate how the addition of Vivos Therapeutics to your portfolios can decrease your overall portfolio volatility.